HER2-Positive Breast Cancer affects 25% of women with the disease. It's described as agressive and often times people are given a poor prognosis, but there's a new treatment for it that has been approved by the FDA and it's helping people with that type of disease live longer.
I had the opportunity to do a satellite interview with Dr. Robert Hermann and his patient Ann Wertz, both played a part in clinical trials for this new treatment. You can see that interview by watcing the video above.
Ann was diagnosed with HER2-Positive breast cancer back in 2005. Then, in 2011, she found out the cancer spread yet again and doctors didn't give her long to live. So, she received that treatment through a clinical trial and her cancer has been kept at bay for nearly 2 years now.